Office of the Chief Science Officer; The Ethics Subcommittee of the Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention (CDC), and the Public Health Ethics Committee, Office of the Chief Science Officer, CDC, 7046 [E6-1822]
Download as PDF
<![CDATA[
7046
Federal Register / Vol. 71, No. 28 / Friday, February 10, 2006 / Notices
Respondents
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hours)
Project Organizations ..................................................................................................................
10
2
77/60
Betsey Dunaway,
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
both CDC and the Agency for Toxic
Substances and Disease Registry.
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E6–1828 Filed 2–9–06; 8:45 am]
Centers for Disease Control and
Prevention
Dated: February 6, 2006.
Alvin Hall,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E6–1822 Filed 2–9–06; 8:45 am]
Dated: February 2, 2006.
Office of the Chief Science Officer; The
Ethics Subcommittee of the Advisory
Committee to the Director (ACD),
Centers for Disease Control and
Prevention (CDC), and the Public
Health Ethics Committee, Office of the
Chief Science Officer, CDC
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Committee to the Director,
Centers for Disease Control and
Prevention: Notice of Charter Renewal
This gives notice under the Federal
Advisory Committee Act (Pub. L. 92–
463) of October 6, 1972, that the
Advisory Committee to the Director,
Centers for Disease Control and
Prevention, of the Department of Health
and Human Services, has been renewed
for a 2-year period extending through
February 1, 2008.
For further information contact: Lynn
Austin, Ph.D, Executive Secretary,
Advisory Committee to the Director,
Centers for Disease Control and
Prevention, Department of Health and
Human Services, 1600 Clifton Road,
NE., M/S D–14, Atlanta, Georgia 30333,
telephone 404–639–7000 or fax 404/
498–7111.
The Director, Management and
Analysis and Services Office, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: February 2, 2006.
rmajette on PROD1PC67 with NOTICES1
Diane Allen,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 06–1202 Filed 2–9–06; 8:45 am]
BILLING CODE 4163–18–P
VerDate Aug<31>2005
15:10 Feb 09, 2006
Jkt 208001
BILLING CODE 4163–18–P
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), CDC announces the
following committee meeting.
Centers for Disease Control and
Prevention
Name: Joint Meeting of the Ethics
Subcommittee, ACD, CDC, and CDC’s Public
Health Ethics Committee.
Time and Date: 9 a.m.–3:30 p.m., February
16, 2006.
Place: CDC Global Communications Center
(Building 19), 1600 Clifton Road, Atlanta,
Georgia 30333.
Status: Open to the public, limited only by
the space available. The meeting room
accommodates approximately 60 people.
Purpose: The meeting will provide a report
on the progress of CDC’s efforts to increase
the capacity of public health ethics, to
manage issues involving public health ethics,
and to identify the current and future public
health ethics needs and priorities at CDC.
Matters To Be Discussed: Agenda items
will include highlights of public health
activities in 2005; public health ethics at CDC
in 2006 and the future; a report on the
Pandemic Influenza Planning consultation;
public health ethics challenges (focus on
science); and a discussion on needs,
priorities, and action steps.
Agenda items are subject to change as
priorities dictate.
Due to administrative issues that had to be
resolved, the Federal Register notice is being
published less than fifteen days before the
date of the meeting.
Contact Person For More Information: Jan
Devier, Dr.P.H., M.P.A., Health Scientist and
Senior Advisor, Science Vision and Alliances
Team, Office of the Chief Science Officer,
1600 Clifton Road, NE., M.S. D–50, Atlanta,
Georgia 30333. Telephone (404) 639–4690.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities for
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Advisory Committee on Immunization
Practices: Meeting
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC) announce
the following Federal Committee
meeting.
Correction: To include a Vaccines for
Children vote on influenza.
Name: Advisory Committee on
Immunization Practices (ACIP).
Times and Dates: 8 a.m.–6:15 p.m.,
February 21, 2006. 8 a.m.–5 p.m., February
22, 2006.
Place: Centers for Disease Control and
Prevention, 1600 Clifton Road, NE., Building
19, Room 232, Atlanta, Georgia 30333.
For Further Information Contact: Demetria
Gardner, Epidemiology and Surveillance
Division, National Immunization Program,
CDC, 1600 Clifton Road, NE., (E–61), Atlanta,
Georgia 30333, telephone 404/639–8096, fax
404/639–8616.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities for
both the CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: February 6, 2006.
Alvin Hall,
Director, Management Analysis and Services
Office Centers for Disease Control and
Prevention.
[FR Doc. E6–1823 Filed 2–9–06; 8:45 am]
BILLING CODE 4163–18–P
E:\FR\FM\10FEN1.SGM
10FEN1
]]>Agencies
[Federal Register Volume 71, Number 28 (Friday, February 10, 2006)]
[Notices]
[Page 7046]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-1822]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Office of the Chief Science Officer; The Ethics Subcommittee of
the Advisory Committee to the Director (ACD), Centers for Disease
Control and Prevention (CDC), and the Public Health Ethics Committee,
Office of the Chief Science Officer, CDC
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), CDC announces the following committee
meeting.
Name: Joint Meeting of the Ethics Subcommittee, ACD, CDC, and
CDC's Public Health Ethics Committee.
Time and Date: 9 a.m.-3:30 p.m., February 16, 2006.
Place: CDC Global Communications Center (Building 19), 1600
Clifton Road, Atlanta, Georgia 30333.
Status: Open to the public, limited only by the space available.
The meeting room accommodates approximately 60 people.
Purpose: The meeting will provide a report on the progress of
CDC's efforts to increase the capacity of public health ethics, to
manage issues involving public health ethics, and to identify the
current and future public health ethics needs and priorities at CDC.
Matters To Be Discussed: Agenda items will include highlights of
public health activities in 2005; public health ethics at CDC in
2006 and the future; a report on the Pandemic Influenza Planning
consultation; public health ethics challenges (focus on science);
and a discussion on needs, priorities, and action steps.
Agenda items are subject to change as priorities dictate.
Due to administrative issues that had to be resolved, the
Federal Register notice is being published less than fifteen days
before the date of the meeting.
Contact Person For More Information: Jan Devier, Dr.P.H.,
M.P.A., Health Scientist and Senior Advisor, Science Vision and
Alliances Team, Office of the Chief Science Officer, 1600 Clifton
Road, NE., M.S. D-50, Atlanta, Georgia 30333. Telephone (404) 639-
4690.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities for both CDC and the Agency for Toxic Substances and
Disease Registry.
Dated: February 6, 2006.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. E6-1822 Filed 2-9-06; 8:45 am]
BILLING CODE 4163-18-P
